MARC N. CASPER - 06 Nov 2023 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Chairman & CEO, Director
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Marc N. Casper
Issuer symbol
TMO
Transactions as of
06 Nov 2023
Net transactions value
-$3,451,369
Form type
4
Filing time
08 Nov 2023, 16:09:24 UTC
Previous filing
06 Nov 2023
Next filing
30 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $1,576,800 +10,000 +7.6% $157.68 141,175 06 Nov 2023 Direct
transaction TMO Common Stock Sale $407,907 -900 -0.64% $453.23 140,275 06 Nov 2023 Direct F1, F2
transaction TMO Common Stock Sale $2,176,262 -4,793 -3.4% $454.05 135,482 06 Nov 2023 Direct F1, F3
transaction TMO Common Stock Sale $1,735,822 -3,816 -2.8% $454.88 131,666 06 Nov 2023 Direct F1, F4
transaction TMO Common Stock Sale $182,392 -400 -0.3% $455.98 131,266 06 Nov 2023 Direct F1, F5
transaction TMO Common Stock Sale $41,670 -91 -0.07% $457.91 131,175 06 Nov 2023 Direct F1
transaction TMO Common Stock Options Exercise $252,288 +1,600 +1.2% $157.68 132,775 07 Nov 2023 Direct
transaction TMO Common Stock Sale $6,368 -14 -0.01% $454.83 132,761 07 Nov 2023 Direct F1
transaction TMO Common Stock Sale $151,856 -331 -0.25% $458.78 132,430 07 Nov 2023 Direct F1, F6
transaction TMO Common Stock Sale $208,280 -453 -0.34% $459.78 131,977 07 Nov 2023 Direct F1, F7
transaction TMO Common Stock Sale $221,122 -480 -0.36% $460.67 131,497 07 Nov 2023 Direct F1, F8
transaction TMO Common Stock Sale $111,705 -242 -0.18% $461.59 131,255 07 Nov 2023 Direct F1, F9
transaction TMO Common Stock Sale $37,074 -80 -0.06% $463.42 131,175 07 Nov 2023 Direct F1
holding TMO Common Stock 5,300 06 Nov 2023 By Alison Casper 2020 Irrevocable Trust F10
holding TMO Common Stock 59,155 06 Nov 2023 By Floral Park Associates, Inc.
holding TMO Common Stock 5,000 06 Nov 2023 By MNC 2020 Irrevocable Trust F11
holding TMO Common Stock 6,000 06 Nov 2023 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -10,000 -86% $0.000000 1,600 06 Nov 2023 Common Stock 10,000 $157.68 Direct F12
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -1,600 -100% $0.000000* 0 07 Nov 2023 Common Stock 1,600 $157.68 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 18, 2022.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $452.49 to $453.48, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), (8) and (9) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $453.49 to $454.46, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $454.49 to $455.47, inclusive.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $455.49 to $456.53, inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $458.18 to $459.00, inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $459.27 to $460.12, inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $460.40 to $461.04, inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $461.44 to $461.81, inclusive.
F10 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F11 The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein.
F12 The option vested in four equal installments on February 28, 2018, 2019, 2020, and 2021.